Acquisition Opportunity Gibraltar Laboratories was acquired by Nelson Labs in 2018 and subsequently by Sotera Health, indicating potential alignment opportunities for portfolio integration, cross-sell of sterilization and analytical services, and access to larger enterprise networks seeking trusted Biopharma QA partners.

Quality Leadership With ISO 17025 certification, FDA registration, AAAL accreditation, and a strong regulatory liaison network, Gibraltar demonstrates high compliance maturity, presenting a compelling case to biopharma and medical device customers seeking validated and reliable sterilization and analytical testing partners.

Expansion Readiness Operating across two NJ sites with a sizable footprint and a 45+ year track record, Gibraltar shows growth velocity and capacity to handle increased testing volume, making it suitable for clients expanding manufacturing or needing scalable analytical services.

Scientific Depth All departments led by PhD or master’s level scientists and a published research footprint create selling points for complex analytical projects, regulatory submissions, and high-stakes validation studies that require expert-level capabilities.

Industry Footprint Active involvement with major trade organizations and regulatory contacts, plus a diversified client base across pharma, medical devices, tissue banks, and cosmetics, positions Gibraltar as a trusted partner for firms seeking integrated sterilization, QA, and testing services.